18,633 reports of this reaction
2.1% of all ASPIRIN 81 MG reports
#7 most reported adverse reaction
HEADACHE is the #7 most commonly reported adverse reaction for ASPIRIN 81 MG, manufactured by Allegiant Health. There are 18,633 FDA adverse event reports linking ASPIRIN 81 MG to HEADACHE. This represents approximately 2.1% of all 906,158 adverse event reports for this drug.
Patients taking ASPIRIN 81 MG who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for ASPIRIN 81 MG, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for ASPIRIN 81 MG:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 18,633 FDA reports for ASPIRIN 81 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.1% of all adverse event reports for ASPIRIN 81 MG, making it a notable side effect.
If you experience headache while taking ASPIRIN 81 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.